Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Proposes Dropping IVIG Preadministration Fee In 2009

Executive Summary

CMS is proposing to drop a $37 Medicare payment to hospitals for "preadministration" services related to intravenous immune globulin therapies in 2009, a move that will "further disrupt" care for those in need of IVIG, according to an industry group

You may also be interested in...



Stakeholders Oppose Proposal To Cut IVIG Preadministration Fee In Medicare

Industry groups are asking CMS to back off on a proposal to cut the $37 preadministration fee for intravenous immune globulin therapies administered in the hospital outpatient setting

Stakeholders Oppose Proposal To Cut IVIG Preadministration Fee In Medicare

Industry groups are asking CMS to back off on a proposal to cut the $37 preadministration fee for intravenous immune globulin therapies administered in the hospital outpatient setting

Medicare IVIG Payment Study, Short-Term Fix Proposed By Sen. Kerry

Sen. John Kerry, D-Mass., is bringing Medicare reimbursement for intravenous immune globulin therapies back into the spotlight, with legislation he hopes might be attached to an eventual Medicare physician payment package

Related Content

UsernamePublicRestriction

Register

PS049856

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel